OVERVIEW

Over the course of two days, The San Diego Cardiovascular Interventions Symposium, will focus on disseminating the knowledge and evidence-based data regarding novel and innovative therapeutic options for patients with complex coronary, structural and peripheral vascular disease. The symposium will focus on the use of advanced techniques and technologies including robotics, atherectomy, hemodynamic support devices and the use of intravascular imaging and physiology for optimal cardiovascular revascularization. The impact of COVID-19 on the field of interventional cardiology and patient care will be addressed. New coronary CTO techniques and tools, indications for left main and bifurcation PCI with appropriate techniques will be reviewed. Outcomes of TAVR, percutaneous mitral and tricuspid valve repair, PFO/ASD closure and left atrial appendage closure will be presented. Adjunctive pharmacotherapy for cardiac interventions will be addressed. Participants will observe live cases and hear from international experts.

TARGET AUDIENCE

The San Diego Cardiovascular Interventions Symposium has been designed to meet the needs of Interventional Cardiologists, Clinical Cardiologists, Internists, Residents, Fellows in Training, Cath Lab Nurses and Technicians as well as other Allied Healthcare professionals with an interest in the field of cardiology.

LEARNING OBJECTIVES

Upon completion of this course, participants should be able to:

• Identify the impact of COVID-19 on STEMI care and the field of interventional cardiology
• Identify new techniques and technologies for CTO, bifurcation and left main PCI
• Identify the role of various lesion modifications/atherectomy techniques prior to coronary stenting
• Identify the utility of adjunctive hemodynamic support to facilitate complete coronary revascularization and    high-risk PCI
• Identify the advantages and utility of robotic PCI
• Review the data and indications for percutaneous VADs in severe decompensated CHF and cardiogenic shock
• Review the contemporary data and indications for TAVR
• Identify the role of left atrial appendage closure and percutaneous mitral valve repair
• Identify optimal oral and intravenous antiplatelet therapy for PCI
• Review optimal utilization of FFR, IVUS, and OCT in reducing inappropriate PCI
• Identify appropriate patients and approaches for peripheral vascular interventions
• Identify occupational hazards of interventive cardiology and strategies to reduce radiation association risk

ACCREDITATION

The University of California San Diego School of Medicine designates this live activity for a maximum of 13.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.